Blog
The Squeeze Is On For EVGo, Rally To Follow
If you’ve been watching the short interest in EVGo (NYSE: EVGO) and wondering when and if a squeeze will happen, it is. The company’s q4 results and outlook affirm the business potential and have
Is The Bottom In For RH, Or Is This Just A Stopping Point?
Signs within the RH (NYSE: RH) report indicate that a bottom could be in play for the stock. While results are worse than the Marketbeat.com consensus figures and the guidance is poor, there is an
Dividend King H.B. Fuller Signals Slowing In 2023
Dividend King H.B. Fuller (NYSE: FUL) is not an exciting stock but can be a telling indicator of economic activity. The company makes glue and adhesives for all end market uses, a leading input
Is SoFi Technologies a Buy in the Midst of a Banking Crisis?
Every investor knows that “let the buyer beware” is always sound advice. And when you throw in a global banking crisis, that should make investors very cautious. In the midst of this, it can be
3 Companies That Just Started Paying Dividends
Dividend stocks come in many shapes and sizes. Large caps and small caps. Quarterly and monthly payers. High yield. Dividend growers.
And then there are dividend initiators.
The newbies of the
Unifirst Is The Next Cintas And Why It Matters For Investors
Unifirst (NYSE: UNF) is fast becoming the next Cintas (NASDAQ: CTAS), which matters for several reasons. Competition for Cintas aside, Cintas is a blue-chip business services company with robust
Analysts Upgrade Ciena Corp to Strong Buy
Oppenheimer and Raymond James financial analysts upgraded Ciena Corp.'s (NYSE: CIEN) rating from Outperform to Strong Buy this week. The sentiment bump also helped push share value up by 3.1% on
Alibaba Just Changed The Game For Chinese Tech Conglomerates
The Chinese equity market has been out of favor since the United States decided to stimulate the economy with newly printed dollar bills and rock-bottom interest rates as a way to pull the nation
Monster Beverage: Strong Earnings Forecast, Bullish Chart Pattern
Monster Beverage Corp. (NASDAQ: MNST) is holding steady in a flat base with an 8% correction, after hitting resistance at $52.75, following a 2-for-1 stock split. The stock began trading on an
CloudFlare's Chart Shows Bullish Moving-Average Crossover
Shares of pandemic-era growth winner CloudFlare Inc. (NYSE: NET) are forming a bullish correction near their 10-week moving average.
In another piece of good news, the stock’s 50-day line
Dave & Buster’s Rebound Could Score for Investors
Dave & Buster's Entertainment Inc. (NASDAQ: PLAY) has been working hard to improve its operations and growth capability since the pandemic began. The restaurant rebound has helped drive revenue
Cal-Maine: Is it Time to Chase this Stock Higher?
Chasing stock prices higher is rarely a sound investment strategy, but there are times when it can pay off, and Cal-Maine Foods Inc. (NASDAQ: CALM) might be one of them. Dynamics within the
The Most Important Warren Buffett Stock for Investors: His Own
Investors could do worse than buying stocks owned by Warren Buffett. Some of the most famous Warren Buffett stocks include Apple Inc. (NASDAQ: AAPL), The Coca-Cola Company (NYSE: KO) and Bank of
Three Mid Caps Wall Street Sees Doubling Within 12 Months
In the stock market, big hits have been more challenging to uncover, including among the best mid-cap stocks.
Over the past 12 months, less than 1% of some 6,600 U.S. stocks have doubled or
It’s No Stretch: Lululemon Could Break Out of its Range
The price action in Lululemon Athletica Inc. (NASDAQ: LULU) became muted for the last several quarters due to fears of slowing growth and underperformance that have yet to materialize. The latest
Visa: Turnkey Investment to Finance Inflation-Tightened Wallets
Throughout the economic history of the United States, every recession has brought on a typical interest rate cycle caused by dire economic circumstances, followed by increased inflation and asset
Three Pullback Opportunities in Tech Right Now
Despite massively underperforming the broader market in 2022, the tech sector has underperformed this year. Nowhere is this more obvious than in the major indices, with the tech-heavy NASDAQ up a
Micron Technology Goes on Breakout Watch
Micron Technology Inc. (NASDAQ: MU) moves higher on solid results and has the analysts doubling down on their outlook. The Q2 results were a bit of a surprise but show that the bottom in the memory
3 Undervalued Dividend Payers For Volatile Market Conditions
M.D.C. Holdings, Inc. (NYSE: M.D.C.) Radian Group Inc. (NYSE: RDN) and Century Communities (NYSE: CCS) are three undervalued dividend payers. All are involved with some aspect of the home-buying
3 More Downgrades To Put On Your Buy List
Marketbeat’s stock screening tools are a great place to find interesting stock plays, including the screen for Most Downgrades Stocks. Stocks with downgrades can signal many things, and one of
Triple-Digit Gains Are In Store For The Lovesac Company
Shares of The Lovesac Company (NASDAQ: LOVE) are up more than 15% following a solid report and may go even higher. This company benefits from sustained strength in the furniture industry, but
3 Oversold Large Caps With Rebound Potential
Volatility has been on full display for the last couple of weeks. Concerns about the global banking system, interest rates and mixed economic data are keeping investors on the edge of their seats
New All-Time Highs in Store for Cintas
Cintas Corp. (NASDAQ: CTAS) and others in the employer services industry are riding a wave of business that has yet to end. The pandemic caused a consolidation within the industry that led to
After an Earnings Blowout, Is Ciena Stock a Buying Opportunity?
Global networking solutions provider Ciena Corporation (NYSE: CIEN) stock has struggled to breakout of a weekly ascending triangle pattern despite its blowout Q1 2023 earnings report. Ciena is a
Here’s Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
Clinical-stage biotechnology company Viking Therapeutics, Inc. (NASDAQ: VKTX) stock jumped more than 50% on positive Phase 1 data on its novel dual GLP-1/GLP agonist compound VK2735 for the

